A Score Based on NfL and Glial Markers May Differentiate Between Relapsing–Remitting and Progressive MS Course

Background: The diagnostic use of biomarkers in body fluids of multiple sclerosis (MS) patients allows the monitoring of different pathophysiological aspects of the disease. We previously reported elevated cerebrospinal fluid (CSF) and serum levels of glial fibrillary acidic protein (GFAP) but not n...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Front Neurol
Hauptverfasser: Huss, André, Otto, Markus, Senel, Makbule, Ludolph, Albert C., Abdelhak, Ahmed, Tumani, Hayrettin
Format: Artigo
Sprache:Inglês
Veröffentlicht: Frontiers Media S.A. 2020
Schlagworte:
Neurology
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7378743/
https://ncbi.nlm.nih.gov/pubmed/32765393
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2020.00608
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge